Coherus Oncology, Inc.
CHRS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001512762
No open-market purchases or sales by Coherus Oncology, Inc. insiders were filed in the last 90 days; 146 institutions reported holding it in 13F filings for Q2 2026, worth $98.5M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Coherus Oncology, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 158 | 2 | 146 | −10 |
| Shares | 71.6M | 70.4K | 70.3M | −1.18M (−1.6%) |
| Value | $120.8M | $118.9K | $98.5M | −$22.2M (−18.4%) |
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held Coherus Oncology, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Canton Hathaway, LLC | 58,230 | $81.5K | 0.02% |
| EntryPoint Capital, LLC | 24,377 | $34.1K | 0.01% |
| Confluence Wealth Services, Inc. | 19,803 | $27.7K | 0.00% |
| Spark Investment Management LLC | 17,800 | $24.9K | 0.05% |
| Brighton Jones LLC | 12,803 | $17.9K | 0.00% |
| Xponance, Inc. | 12,434 | $17.4K | 0.00% |
| Kingsbury Capital Investment Advisors LLC | 12,396 | $17.4K | 0.01% |
| KMT Wealth Management, LLC | 12,396 | $17.4K | 0.01% |
| Two Sigma Securities, LLC | 10,043 | $14.1K | 0.00% |
| Caitong International Asset Management Co., Ltd | 11 | $15 | 0.00% |
Sold out (20)
Institutions that held Coherus Oncology, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Tang Capital Management LLC | 1,886,748 | $3.19M |
| Propel Bio Management, LLC | 1,420,550 | $2.41M |
| EAM Investors, LLC | 309,801 | $523.6K |
| Marshall Wace, LLP | 270,087 | $456.4K |
| Simplify Asset Management Inc. | 253,140 | $427.8K |
| Dauntless Investment Group, LLC | 76,087 | $128.6K |
| American Century Companies Inc | 43,242 | $73.1K |
| Diversified Trust Co | 38,471 | $65.0K |
| Virtu Financial LLC | 25,835 | $44.0K |
| Nine Masts Capital Ltd | 23,018 | $38.9K |
| Engineers Gate Manager LP | 22,658 | $38.3K |
| Quadrature Capital Ltd | 17,775 | $30.0K |
| Wealth Group, Ltd. | 14,195 | $24.0K |
| Lazard Asset Management LLC | 10,514 | $17.8K |
| SWAN Capital LLC | 1,300 | $2.20K |
| Sound Income Strategies, LLC | 200 | $348 |
| Root Financial Partners, LLC | 199 | $336 |
| MAI Capital Management | 115 | $195 |
| Larson Financial Group LLC | 40 | $68 |
| Wealth Preservation Advisors, LLC | 8 | $14 |
Not filed for Q2 2026 yet (2)
Institutions that held Coherus Oncology, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| CWM, LLC | 70,341 | $118.9K |
| Sunbelt Securities, Inc. | 16 | $27 |